Search Results - "Magnan, Heather D."

A phase 1/2 study of REGN5093-M114, a METxMET antibody-drug conjugate, in patients with mesenchymal epithelial transition factor (MET)-overexpressing NSCLC by Drilon, Alexander E., Awad, Mark M., Gadgeel, Shirish M., Villaruz, Liza C, Sabari, Joshua K., Perez, Javier, Daly, Christopher, Patel, Shraddha, Li, Siyu, Seebach, Frank A., Lowy, Israel, Magnan, Heather D., Rietschel, Petra

“…TPS8593 Background: MET, also called hepatocyte growth factor receptor (HGFR), is a high-affinity transmembrane protein receptor for HGF. MET is overexpressed…”
Get full text

Off-label use of bevacizumab in relapsed and refractory pediatric sarcoma patients: The Memorial Sloan Kettering Cancer Center Experience by Slotkin, Emily Kanaya, Magnan, Heather D., Meyers, Paul A., Chou, Alexander J., Ambati, Srikanth R., Wexler, Leonard H.

“…Abstract only…”
Get full text

A pilot trial of irinotecan, temozolomide and bevacizumab (ITB) for treatment of newly diagnosed patients with desmoplastic small round cell tumor (DSRCT) by Magnan, Heather D., Price, Anita, Chou, Alexander J., Riedel, Elyn, Wexler, Leonard H., Ambati, Srikanth R., Slotkin, Emily Kanaya, Ulaner, Gary, Modak, Shakeel, La Quaglia, Michael P., Meyers, Paul A.

“…Abstract only 11050 Background: DSRCT is a rare tumor with a dismal prognosis in the setting of current treatment options. Preclinical data suggested that…”
Get full text

Predictors of overall survival in patients diagnosed with desmoplastic small round cell tumor (DSRCT) by Shoushtari, Alexander Noor, Qin, Li-Xuan, Kuk, Deborah, Magnan, Heather D., Modak, Shakeel, Wolden, Suzanne L., Cho, Eun Jung, Pallos, Valerie, Grubman, Olivia, Viny, Aaron D., Carvajal, Richard D., Chi, Ping, D'Angelo, Sandra P., Dickson, Mark Andrew, Keohan, Mary Louise, Tap, William D., La Quaglia, Michael P., Gounder, Mrinal M.

“…Abstract only…”
Get full text

20-Year Experience With Intraoperative High-Dose-Rate Brachytherapy for Pediatric Sarcoma: Outcomes, Toxicity, and Practice Recommendations by Folkert, Michael R., MD, PhD, Tong, William Y., MD, LaQuaglia, Michael P., MD, Wexler, Leonard H., MD, Chou, Alexander J., MD, Magnan, Heather, MD, Zelefsky, Michael J., MD, Wolden, Suzanne L., MD

“…Purpose To assess outcomes and toxicity of high-dose-rate intraoperative radiation therapy (HDR-IORT) in the management of pediatric sarcoma. Methods and…”
Get full text

Reduced Toxicity With Intensity Modulated Radiation Therapy (IMRT) for Desmoplastic Small Round Cell Tumor (DSRCT): An Update on the Whole Abdominopelvic Radiation Therapy (WAP-RT) Experience by Desai, Neil B., MD, MHS, Stein, Nicholas F., MS, LaQuaglia, Michael P., MD, Alektiar, Kaled M., MD, Kushner, Brian H., MD, Modak, Shakeel, MD, Magnan, Heather M., MD, Goodman, Karyn, MD, Wolden, Suzanne L., MD

“…Purpose Desmoplastic small round cell tumor (DSRCT) is a rare malignancy typically involving the peritoneum in young men. Whole abdominopelvic radiation…”
Get full text